Takanori Mukozu

Serum VEGF as a tumor marker in patients with HCV-related liver cirrhosis and hepatocellular carcinoma.

Takanori Mukozu, Hidenari Nagai, Daigo Matsui et al. · PubMed · 2013 · 66 citations

Sorafenib Prevents Escape from Host Immunity in Liver Cirrhosis Patients with Advanced Hepatocellular Carcinoma

Hidenari Nagai, Takanori Mukozu, Daigo Matsui et al. · Clinical and Developmental Immunology · 2012 · 30 citations · Full text

VEGF in patients with advanced hepatocellular carcinoma receiving intra-arterial chemotherapy.

Daigo Matsui, Hidenari Nagai, Takanori Mukozu et al. · PubMed · 2015 · 20 citations

SATB1 Conditional Knockout Results in Sjögren’s Syndrome in Mice

Yuriko Tanaka, Takehiko Sotome, Akiko Inoue et al. · The Journal of Immunology · 2017 · 20 citations

Sorafenib and hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma with portal vein tumor thrombus.

Hidenari Nagai, Takanori Mukozu, Yuu Ogino et al. · PubMed · 2015 · 19 citations